Cardiovascular Disease Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2028
The global cardiovascular disease drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cardiovascular diseases are caused due to abnormal cardiac structure and function. These diseases are a range of chronic progressive disorders that affect the blood pumping capacity of the heart muscles, leading to an insufficient supply of blood to the whole body. Cardiovascular diseases have a significant burden on the global healthcare system, affecting more than 26 million people across the globe. It is estimated that heart failure across the globe had cost around $100 billion in 2012. Among these, the growing global population suffering from cardiovascular illnesses is the primary factor for the increased demand for cardiovascular disease drugs. This is the primary factor contributing to the global cardiovascular disease drugs market.
To Request a Sample of our Report on Cardiovascular
Disease Drugs Market: https://www.omrglobal.com/request-sample/cardiovascular-disease-drugs-market
Globally, almost 15 million
people suffer from heart attacks or similar issues, according to the World
Heart Federation. Heart disease claims the lives of around 659,000 people in
the US each year, accounting for one out of every four mortalities. Between
2016 and 2017, the US spent $363 billion on heart disease. This covers the
costs of healthcare services, medications, and lost productivity as a result of
mortality. The most frequent type of heart illness, coronary heart disease,
affects approximately 18.2 million persons aged 20 and up (about 6.7%). Adults
under the age of 65 account for about 2 out of every 10 mortalities due to
coronary artery disease. These estimates lead to an increased demand for
effective solutions such as cardiovascular disease drugs, thereby augmenting
the global cardiovascular disease drugs market.
Market Coverage
•
The market number available for – 2021-2028
•
Base year- 2021
•
Forecast period- 2022-2028
Segment Covered-
•
By Drug Class
•
By Disease Indication
Regions covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape:
Amgen Inc., Pfizer Inc., and Baxter International Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Cardiovascular Disease Drugs Market is Available @ https://www.omrglobal.com/industry-reports/cardiovascular-disease-drugs-market
Global Cardiovascular Disease Drugs Market Report by
Segment
By Drug Class
• Anti-Hyperlipidemics
• Anticoagulants
• Anti-Arrhythmics
• Others
By Disease Indication
• Coronary
Artery Disease
• Arrhythmia
• Hypertension
• Hyperlipidemia
• Others
Global Cardiovascular Disease Drugs Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment